Login to Your Account



Inex, Enzon, ILEX, Genzyme Part Of Today's ODAC Panel

By Aaron Lorenzo


Wednesday, December 1, 2004
WASHINGTON - The FDA's oncology advisory committee is meeting today to form an opinion on two cancer drugs, clofarabine and Marqibo, and a review of the latter could prove dicey based on a briefing document made public by the agency Tuesday. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription